1. |
刘臻, 张强, 马文锋, 等. 上皮钙黏蛋白和α-连接素的表达与乳腺癌生物学特性的关系 [J]. 中国普外基础与临床杂志, 2005; 12(3)∶226.
|
2. |
刘臻, 张强, 马文锋, 等. 上皮钙黏蛋白、 α-连环素和β-连环素在乳腺癌中的表达及意义 [J]. 中华外科杂志, 2005; 43(5)∶307.
|
3. |
Chang HJ, Jee CD, Kim WH. Mutation and altered expression of beta-catenin during gallbladder carcinogenesis [J]. Am J Surg Pathol, 2002; 26(6)∶758.
|
4. |
Rashid A, Gao YT, Bhakta S, et al. Beta-catenin mutations in biliary tract cancers: a population-based study in China [J]. Cancer Res, 2001; 61(8)∶3406.
|
5. |
Park WS, Oh RR, Park JY, et al. Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer [J]. Cancer Res, 1999; 59(17)∶4257.
|
6. |
董泾青, 沈祖楹, 于扬, 等. β-catenin和APC蛋白在甲状腺肿瘤中的表达及意义 [J]. 贵阳医学院学报, 2002; 27(6)∶471.
|
7. |
Muller T, Choidas A, Reichmann E, et al. Phosphorylation and free pool of beta-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration [J]. J Biol Chem, 1999; 274(15)∶10173.
|
8. |
Karim R, Tse G, Putti T, et al. The significance of the Wnt pathway in the pathology of human cancers [J]. Pathology, 2004; 36(2)∶120.
|
9. |
Fearnhead NS, Britton MP, Bodmer WF. The ABC of APC [J]. Hum Mol Genet, 2001; 10(7)∶721.
|
10. |
Bankfalvi A, Terpe HJ, Breukelmann D, et al. Immunophenotypic and prognostic analysis of E-cadherin and beta-catenin expression during breast carcinogenesis and tumour progression: a comparative study with CD44 [J]. Histopathology, 1999; 34(1)∶25.
|
11. |
Michaelson JS, Leder P. beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland [J]. Oncogene, 2001; 20(37)∶5093.
|
12. |
Imbert A, Eelkema R, Jordan S, et al. Delta N89 beta-catenin induces precocious development, differentiation, and neoplasia in mammary gland [J]. J Cell Biol, 2001; 153(3)∶555.
|
13. |
Miyaki M, Iijima T, Kimura J, et al. Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer [J]. Cancer Res, 1999; 59(18)∶4506.
|
14. |
Miyoshi Y, Iwao K, Nagasawa Y, et al. Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3 [J]. Cancer Res, 1998; 58(12)∶2524.
|
15. |
Fukuchi T, Sakamoto M, Tsuda H, et al. Beta-catenin mutation in carcinoma of the uterine endometrium [J]. Cancer Res, 1998; 58(16)∶3526.
|
16. |
Palacios, Gamallo C. Mutations in the β-catenin gene (CTNNB1) in endometrioid ovarian carcinomas [J]. Cancer Res, 1998; 58(7)∶1344.
|
17. |
Voeller HJ, Truica CI, Gelmann EP. Beta-catenin mutations in prostate cancer [J]. Cancer Res, 1998; 58(12)∶2520.
|
18. |
Zhuang SM, Wiseman RW, Soderkvist P. et al. Frequent mutations of the Trp53, Hras1 and beta-catenin (Catnb) genes in 1, 3-butadiene-induced mammary adenocarcinomas in B6C3F1 mice [J]. Oncogene, 2002; 21(36)∶5643.
|
19. |
Jonsson M, Borg A, Nilbert M, et al. Involvement of adenomatous polyposis coli (APC)/beta-catenin signalling in human breast cancer [J]. Eur J Cancer, 2000; 36(2)∶242.
|
20. |
Suriano G, Vrcelj N, Senz J, et al. beta-catenin (CTNNB1) gene amplification: a new mechanism of protein overexpression in cancer [J]. Genes Chromosomes Cancer, 2005; 42(3)∶238.
|
21. |
Mao J, Wang J, Liu B, et al. Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway [J]. Mol Cell, 2001; 7(4)∶801.
|